Position in ALEC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$77,847
-$7,460 QoQ
Shares Held
36,208
+25.6% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,503,407 across 207 Biotechnology names. ALEC ranks #200 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in ALEC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $77,847 | 36,208 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $85,307 | 28,820 | Shares | Defined | 2025-11-13 | |
| 2024-12-31 | $10,334 | 5,468 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $234,719 | 50,369 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $228,675 | 50,369 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $207,166 | 34,413 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $253,963 | 31,825 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $206,226 | 31,825 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $191,268 | 31,825 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $196,996 | 31,825 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $293,744 | 31,825 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $301,064 | 31,825 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $323,342 | 31,825 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $453,506 | 31,825 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $424,336 | 20,549 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $468,928 | 20,549 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $389,875 | 18,717 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $376,960 | 18,717 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $314,915 | 20,814 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $219,275 | 20,814 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $508,694 | 20,814 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $346,651 | 14,366 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||